Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


At least four killed in Israeli strike on building in Lebanon's Baalbek
Qatar busts two cells linked to Iran’s Revolutionary Guard
GCC condemns Iranian attack on Port of Fujairah
Jordanian airspace reopens after 'comprehensive review'
